Anders Fink-Jensen
Clinical Professor
- 2024
- Published
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis
Kushner, R. F., Fink-Jensen, Anders, Frenkel, O., McGowan, B., Goldman, B., Overvad, M. & Wadden, T., 2024, In: Obesity. 32, 2, p. 273-280 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- E-pub ahead of print
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study
Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Virtual reality-assisted cognitive behavioral therapy for patients with alcohol use disorder: a randomized feasibility study
Thaysen-Petersen, D., Hammerum, S. K., Vissing, A., Oestrich, I. H., Nordentoft, Merete, Düring, S. W. & Fink-Jensen, Anders, 2024, In: Frontiers in Psychiatry. 15, 12 p., 1337898.Research output: Contribution to journal › Journal article › Research › peer-review
- 2023
- Published
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Sass, M. R., Danielsen, A. A., Köhler-Forsberg, O., Storgaard, H., Knop, Filip Krag, Nielsen, Mette Ødegaard, Sjödin, Anders Mikael, Mors, O., Correll, C. U., Ekstrøm, Claus Thorn, Vinberg, Maj, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2023, In: BMJ Open. 13, 1, 10 p., e068652.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
Leggio, L., Hendershot, C. S., Farokhnia, M., Fink-Jensen, Anders, Klausen, M. K., Schacht, J. P. & Simmons, W. K., 2023, In: Nature Medicine. 29, 12, p. 2993-2995 3 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series
Prasad, F., De, R., Korann, V., Chintoh, A. F., Remington, G., Ebdrup, Bjørn, Siskind, D., Knop, Filip Krag, Vilsbøll, Tina, Fink-Jensen, Anders, Hahn, M. K. & Agarwal, S. M., 2023, In: Therapeutic Advances in Psychopharmacology. 13, 10 p., 20451253231165169.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effectiveness of oxytocin for treating substance use disorders: A systematic review of randomized placebo-controlled trials
Mellentin, A. I., Finn, S. W., Skøt, L., Thaysen-Petersen, D., Mistarz, N., Fink-Jensen, Anders & Nielsen, D. G., 2023, In: Neuroscience and Biobehavioral Reviews. 151, 16 p., 105185.Research output: Contribution to journal › Review › Research › peer-review
- Published
The use of classic psychedelics among adults: a Danish online survey study
Søgaard Juul, T., Ebbesen Jensen, M. & Fink-Jensen, Anders, 2023, In: Nordic Journal of Psychiatry. 77, 4, p. 367-378Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Virtual reality-assisted cognitive behavioural therapy for outpatients with alcohol use disorder (CRAVR): A protocol for a randomised controlled trial
Thaysen-Petersen, D., Hammerum, S. K., Vissing, A. C., Arnfred, B. T., Nordahl, R., Adjorlu, A., Nordentoft, Merete, Oestrich, I. H., Düring, S. W. & Fink-Jensen, Anders, 2023, In: BMJ Open. 13, 3, e068658.Research output: Contribution to journal › Journal article › Research › peer-review
- 2022
- Published
Possible Tacrolimus-Related Neuropsychiatric Symptoms: One Year After Allogeneic Hematopoietic Cell Transplantation: A Case Report
Løhde, L. W., Bentzon, A., Kornblit, B. T., Roos, P. & Fink-Jensen, Anders, Mar 2022, In: Clinical Medicine Insights: Case Reports. 15Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clozapine- and non-clozapine-associated neutropenia in patients with schizophrenia: a retrospective cohort study
Johannsen, C., Petersen, Tonny Studsgaard, Nielsen, Jimmi, Jørgensen, Anders, Jimenez-Solem, E. & Fink-Jensen, Anders, 2022, In: Therapeutic Advances in Psychopharmacology. 12, p. 1-11 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial
Pagsberg, Anne Katrine, Krogmann, A., Jeppesen, Pia, von Hardenberg, L., Klauber, D. G., mfw347, mfw347, Rudå, Ditte, Decara, M. S., Jepsen, J. R. M., Fagerlund, Birgitte, Fink-Jensen, Anders, Correll, C. U. & Galling, B., 2022, In: Journal of the American Academy of Child and Adolescent Psychiatry. 61, 8, p. 997-1009Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
Klausen, M. K., Jensen, M. E., Møller, M., le Dous, N., Jensen, A-M. Ø., Zeeman, V. A., Johannsen, C-F., Lee, A. M., Thomsen, G. K., Macoveanu, J., Fisher, P. M., Gillum, M. P., Jørgensen, N. R., Bergmann, M. L., Enghusen Poulsen, H., Becker, U., Holst, J. J., Benveniste, H., Volkow, N. D., Vollstädt-Klein, S. & 5 others, , 2022, In: JCI insight. 19, 20 p., e159863.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit
Flippo, K. H., Trammell, Sam, Gillum, M. P., Aklan, I., Perez, M. B., Yavuz, Y., Smith, N. K., Jensen-Cody, S. O., Zhou, B., Claflin, K. E., Beierschmitt, A., Fink-Jensen, Anders, Knop, Filip Krag, Palmour, R. M., Grueter, B. A., Atasoy, D. & Potthoff, M. J., 2022, In: Cell Metabolism. 34, 2, p. 317-328.e6Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Inactivation of the cholinergic M4 receptor results in a disinhibited endophenotype predicting alcohol use
Molander, A., Thorbek, D. D., Lysne, C., Weikop, Pia, Fink-Jensen, Anders & Wörtwein, Gitta, 2022, In: Behavioural Brain Research. 430, 10 p., 113921.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Proinflammatory biomarkers are associated with prediabetes in patients with schizophrenia
Mller, M., Fredholm, S., Jensen, M. E., Wörtwein, Gitta, Larsen, J. R., Vilsbøll, Tina, Ødum, Niels & Fink-Jensen, Anders, 2022, In: CNS Spectrums. 27, 3, 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
Jensen, M. E., Stenbæk, Dea Siggaard, Juul, T. S., Fisher, P. M., Ekstrøm, Claus Thorn, Knudsen, Gitte Moos & Fink-Jensen, Anders, 2022, In: BMJ Open. 12, 10, 12 p., 066019.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study
Sass, M. R., Juul, T. S., Skov, R., Iversen, Kasper, Harritshøj, L. H., Sørensen, E., Ostrowski, Sisse Rye, Andersen, Ove, Ekstrøm, Claus Thorn, Ullum, H., Nielsen, Jimmi, Hageman, I. & Fink-Jensen, Anders, 2022, In: PLoS ONE. 17, 3, 13 p., e0264325.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The role of glucagon-like peptide 1 (GLP-1) in addictive disorders
Kruse Klausen, M., Thomsen, Morgane, Wörtwein, Gitta & Fink-Jensen, Anders, 2022, In: British Journal of Pharmacology. 179, 4, p. 625-641 17 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events. A nationwide register-based cohort and self-controlled case series study
Wium-Andersen, I. K., Wium-Andersen, M. K., Fink-Jensen, Anders, Rungby, Jørgen, Jørgensen, Martin Balslev & Osler, Merete, 2022, In: Basic & clinical pharmacology & toxicology. 131, 5, p. 372-379 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study
Højlund, M., Wagner, C. B., Wesselhoeft, R., Andersen, K., Fink-Jensen, Anders & Hallas, J., 2022, In: Basic and Clinical Pharmacology and Toxicology. 130, 4, p. 501-512 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2021
- Published
Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents
Wiers, C. E., Vendruscolo, L. F., van der Veen, J. W., Manza, P., Shokri-Kojori, E., Kroll, D. S., Feldman, D. E., McPherson, K. L., Biesecker, C. L., Zhang, R., Herman, K., Elvig, S. K., Vendruscolo, J. C. M., Turner, S. A., Yang, S., Schwandt, M., Tomasi, D., Cervenka, M. C., Fink-Jensen, A., Benveniste, H. & 4 others, , 9 Apr 2021, In: Science Advances. 7, 15, 13 p., eabf6780.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Alkoholafhængighed og komorbid psykisk lidelse
Fink-Jensen, Anders, 5 Apr 2021, In: Ugeskrift for Laeger. 183, 14, 8 p., V01210036.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Brug af virtual reality inden for psykiatrien
Arnfred, B., Thaysen-Petersen, D., Düring, S. W., Fink-Jensen, Anders & Nordentoft, Merete, 1 Mar 2021, In: Ugeskrift for Laeger. 183, 9, 7 p., V07200524.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Exploring Movement Impairments in Patients With Parkinson's Disease Using the Microsoft Kinect Sensor: A Feasibility Study
Rudå, D., Einarsson, G., Andersen, A. S. S., Matthiassen, J. B., Correll, C. U., Winge, K., Clemmensen, L. K. H., Paulsen, R. R., Pagsberg, Anne Katrine & Fink-Jensen, Anders, 6 Jan 2021, In: Frontiers in Neurology. 11, 9 p., 610614.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 916366
Most downloads
-
5759
downloads
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
222
downloads
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
158
downloads
Psychiatric disease as a risk factor in fast-track hip and knee replacement: An overview of the literature
Research output: Contribution to journal › Review › Research › peer-review
Published